These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26523060)

  • 1. Psoriatic Disease: Update on Traditional Disease-modifying Antirheumatic Drugs.
    Marchesoni A; Lubrano E; Cauli A; Ricci M; Manara M
    J Rheumatol Suppl; 2015 Nov; 93():61-4. PubMed ID: 26523060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying antirheumatic drug therapy for psoriatic arthritis.
    Salvarani C; Cantini F; Olivieri I
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).
    Mulder MLM; Vriezekolk JE; den Broeder N; Mahler EAM; Helliwell PS; van den Hoogen FHJ; den Broeder AA; Wenink MH
    Trials; 2020 Feb; 21(1):155. PubMed ID: 32041657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.
    Behrens F; Koehm M; Arndt U; Wittig BM; Greger G; Thaçi D; Scharbatke E; Tony HP; Burkhardt H
    J Rheumatol; 2016 Mar; 43(3):632-9. PubMed ID: 26669916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis.
    Soriano ER
    J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
    Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
    J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
    Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
    J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis.
    Salvarani C; Macchioni P; Olivieri I; Marchesoni A; Cutolo M; Ferraccioli G; Cantini F; Salaffi F; Padula A; Lovino C; Dovigo L; Bordin G; Davoli C; Pasero G; Alberighi OD
    J Rheumatol; 2001 Oct; 28(10):2274-82. PubMed ID: 11669169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab in psoriatic arthritis.
    Salvarani C; Pipitone N; Catanoso M; Chiarolanza I; Boiardi L; Caruso A; Pazzola G; Macchioni P; Di Lernia V; Albertini G
    J Rheumatol Suppl; 2012 Jul; 89():77-81. PubMed ID: 22751600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study.
    Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Lexberg AS; Rødevand E; Kalstad S; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2014 Jan; 73(1):132-7. PubMed ID: 23291385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with cyclosporine in psoriatic arthritis.
    Olivieri I; Salvarani C; Cantini F; Macchioni L; Padula A; Niccoli L; Boiardi L; Portioli I
    Semin Arthritis Rheum; 1997 Aug; 27(1):36-43. PubMed ID: 9287388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.
    Genovese MC; Mease PJ; Thomson GT; Kivitz AJ; Perdok RJ; Weinberg MA; Medich J; Sasso EH;
    J Rheumatol; 2007 May; 34(5):1040-50. PubMed ID: 17444593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.
    Landewé R; Ritchlin CT; Aletaha D; Zhang Y; Ganz F; Hojnik M; Coates LC
    Rheumatology (Oxford); 2019 Jun; 58(6):1025-1033. PubMed ID: 30608620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature.
    Behrens F; Cañete JD; Olivieri I; van Kuijk AW; McHugh N; Combe B
    Rheumatology (Oxford); 2015 May; 54(5):915-26. PubMed ID: 25349441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Tumor Necrosis Factor-α Blockers in Psoriatic Disease. Therapeutic Options in Psoriatic Arthritis.
    Addimanda O; Possemato N; Caruso A; Pipitone N; Salvarani C
    J Rheumatol Suppl; 2015 Nov; 93():73-8. PubMed ID: 26523063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis.
    Appani SK; Devarasetti PK; Irlapati RVP; Rajasekhar L
    Rheumatology (Oxford); 2019 May; 58(5):869-873. PubMed ID: 30590763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary focus on methotrexate in psoriatic disesase.
    Marchesoni A; Ricci M; Moggio E; Brazzelli V; Borroni G
    J Rheumatol Suppl; 2009 Aug; 83():56-8. PubMed ID: 19661543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide in psoriatic arthritis.
    Kaltwasser JP
    Autoimmun Rev; 2007 Sep; 6(8):511-4. PubMed ID: 17854740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological agents in psoriatic arthritis.
    Kocijan R; Muschitz C; Rech J
    Wien Med Wochenschr; 2015 Jan; 165(1-2):36-9. PubMed ID: 25205184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.